| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $225.3M | +107.0% |
| SG&A Expense | $61.6M | +24.6% |
| Operating Income | -$176.6M | -11.6% |
| Pre-tax Income | -$140.7M | -15.1% |
| Income Tax | $515K | +66.1% |
| Net Income | -$141.2M | -15.2% |
| EPS (Basic) | -$0.80 | -2.6% |
| EPS (Diluted) | -$0.80 | -2.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $799.6M | +371.7% |
| Short-term Investments | $646.6M | -9.4% |
| Current Assets | $1.57B | +76.2% |
| Total Assets | $1.58B | +75.3% |
| Current Liabilities | $63.3M | +75.7% |
| Total Liabilities | $67.5M | +75.5% |
| Stockholders' Equity | $1.52B | +75.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$222.2M | -90.5% |
| Capital Expenditures | $3.6M | +180.2% |
| Investing Cash Flow | $89.8M | +125.0% |
| Financing Cash Flow | $762.5M | +48.0% |
| Free Cash Flow | -$225.8M | -91.5% |